IMPACT OF NF-KB EXPRESSION IN THE PROGNOSIS OF MULTIPLE MYELOMA PATIENTS TREATED WITH BORTEZOMIB IN FRONTLINE REGIMENS

EHA Library, Catarina Geraldes, 99976

BORTEZOMIB CONSOLIDATION FOLLOWING ASCT FOR MULTIPLE MYELOMA (MM) IMPROVES RESPONSE DEPTH, WITH ACCEPTABLE TOXICITY AND PRESERVED QUALITY OF LIFE

EHA Library, Neil Rabin, 99977

SUPERIOR EFFICACY OF VTD OVER VCD BEFORE AND AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS

EHA Library, Michele Cavo, 99978

CAN OVERALL SURVIVAL BE IMPROVED IN ELDERLY MULTIPLE MYELOMA PATIENTS?

EHA Library, Bart M.S.Heeg, 99979

MUTATIONAL STATUS AND CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH STRICTLY WHO 2008-DIAGNOSED ESSENTIAL THROMBOCYTHEMIA: A MONOCENTRIC STUDY

EHA Library, Irene Bertozzi, 99980

MATRIX METALLOPROTEINASE 2,3,9,10 AND 13 GENE MUTATIONS IN MYELOPROLIFERATIVE DISEASES

EHA Library, Senem Maral, 99981

SUBCUTANEOUS VERSUS INTRAVENOUS BORTEZOMIB: A REAL-LIFE STUDY ON MULTIPLE MYELOMA PATIENTS

EHA Library, SILVIA MANGIACAVALLI, 99982

CLINICAL FEATURES OF JAPANESE POLYCYTHEMIA VERA AND ESSENTIAL THROMBOCYTHEMIA PATIENTS HARBORING CALR, JAK2V617F, JAK2EX12DEL, AND MPLW515L/K MUTATIONS

EHA Library, Masahiro Okabe, 99983

ACCURACY OF THE SERUM TOTAL LIGHT CHAIN RATIO AS A PREDICTOR OF ABNORMAL SERUM FREE LIGHT CHAIN RATIOS

EHA Library, Marta Pereira, 99984

HIGH PREVALENCE OF RAS PATHWAY MUTATIONS IN CMML PATIENTS WITH HIGH COLONY GROWTH

EHA Library, Klaus Geissler, 99985

CLINICAL DIFFERENCES IN ESSENTIAL THROMBOCYTHEMIA PATIENTS WITH AND WITHOUT THROMBOTIC COMPLICATIONS

EHA Library, Anastasiia Zherniakova, 99986

CIRCULATING ENDOTHELIAL CELLS (CEC) AS A SURROGATE MARKER FOR EVOLUTION IN PH-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS.

EHA Library, Mercedes Rodriguez-Calvillo, 99987

SIMULATION IN CONTINUING EDUCATION: IMPROVING HEMATOLOGIST EVIDENCE-BASED DECISIONS FOR MYELOPROLIFERATIVE NEOPLASM MANAGEMENT

EHA Library, Emily Van Laar, 99989

SERUM LEVELS OF MATRIX METALLOPROTEINASES AND THEIR TISSUE INHIBITORS ARE ELEVATED IN JAK2V617F MUTATED COMPARED TO CALR MUTATED MYELOFIBROSIS AND TRIPLE NEGATIVE ESSENTIAL THROMBOCYTEMIA PATIENTS

EHA Library, Luciene Terezina Lima, 99990

THE MUTATION OF THE SPLICING GENE SRSF2 PERFORMED BY HRM SCREENING IN THE DIAGNOSIS OF CMML.

EHA Library, Melissa Torres Ochando, 99991

TNIP1 AS A NOVEL REARRANGEMENT PARTNER FOR 5Q32 PDGFRB IN EOSINOPHILIA-ASSOCIATED MYELOID NEOPLASM

EHA Library, Arjan Buijs, 99992

MECHANISMS OF FATAL CARDIOTOXICITY FOLLOWING HIGH-DOSE CYCLOPHOSPHAMIDE THERAPY AND A METHOD FOR ITS PREVENTION

EHA Library, Takuro Nishikawa, 99993

PROGRESSION TO MYELOPROLIFERATIVE NEOPLASMS WAS ASSOCIATED WITH MUTATIONS OF THE JAK2 AND CALR GENES IN PATIENTS WITH IDIOPATHIC LEUKOCYTOSIS AND THROMBOCYTOSIS

EHA Library, Naoki Mori, 99994

INTERLABORATORY EVALUATION OF TARGETED NEXT GENERATION SEQUENCING FOR MYELOPROLIFERATIVE NEOPLASMS ASSOCIATED MUTATIONS

EHA Library, Emmanuelle Verger, 99995

THE EFFECTS OF -ADRENERGIC AGONIST OF ISOPROTERENOL ON MIR-886-3P AND MIR-23A EXPRESSION IN HUMAN MESENCHYMAL STEM CELLS

EHA Library, Saeid Kaviani, 99996

COMPARISON OF CONDITIONING REGIMENS FOR RELAPSED / REFRECTORY LYMPHOMA PATIENTS UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANTATION: BEAM VS HIGH DOSE ICE

EHA Library, Ahmet Kursad Gunes, 99997

FERTILITY IN OUR ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS: RESULTS FOR 23 YEARS OF EXPERIENCE

EHA Library, Pervin Topcuoglu, 99998

CD30 EXPRESSION ON NEOPLASTIC MAST CELLS IN SYSTEMIC MASTOCYTOSIS – CORRELATION OF ASSESSMENT BY IMMUNOHISTOCHEMISTRY AND MULTIPARAMETER FLOW CYTOMETRY WITH RESPECT TO CLINICAL PARAMETERS

EHA Library, Frauke Bellos, 99999

INCIDENCE OF CALR MUTATIONS IN PATIENTS WITH CEREBRAL VENOUS THROMBOSIS WITHOUT OVERT CHRONIC MYELOPROLIFERATIVE NEOPLASM

EHA Library, Emmanuelle Verger, 100000

COMPARISON OF THREE DIAGNOSTIC METHODS TO DETECT CALRETICULIN MUTATIONS IN MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Francois Girodon, 100001

ALTERNATIVE SPLICING VARIANT COULD BE RESPONSIBLE OF MORGANA UNDER-EXPRESSION IN ACML

EHA Library, Cristina panuzzo, 100002

MUTATION ANALYSIS OF JAK2, MPL, CALR, ASXL1, TET2, IDH1, IDH2, DNMT3A, AND SF3B1 IN MYELOPROLIFERATIVE NEOPLASM

EHA Library, Jee Hyun Kong, 100003

MARKERS OF CLONAL HEMATOPOIESIS IN PH-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Liubov Poluskina, 100004

HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR PRIMARY IMMUNE DEFICIENY DISEASES: A SINGLE CENTER EXPERIENCE

EHA Library, Turkan Patıroglu, 100005

GATA-1, BUT NOT FOG-1, FLI-1 OR CALR, IS UP-REGULATED IN ESSENTIAL THROMBOCYTHEMIA INDEPENDENTLY FROM JAK2 AND CALR MUTATIONS.

EHA Library, Ciro Rinaldi, 100006

PEGYLATED INTERFERON TREATMENT IMPROVES SURVIVAL IN POLYCYTHEMIA VERA PATIENTS: A SINGLE CENTER EXPERIENCE

EHA Library, Elena Crisà, 100007

TERT RS2736100_C POLYMORPHISM AS PREDISPOSITION FACTOR FOR MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Katalin Piroska Kiss, 100008

PATIENT SELF-CARE INTERVENTIONS: DO THEY IMPACT MPN-RELATED FATIGUE?

EHA Library, Robyn Scheber, 100009

CD4+ CELL COUNT ON DAY + 30 PREDICT OVERALL SURVIVAL AND TRANSPLANT RELATED MORTALITY IN ACUTE LEUKAEMIA PATIENTS AFTER ALLOPBSCT

EHA Library, Domenico Pastore, 100010

ULTRA-DEEP SEQUENCING (UDS) ALLOWS MORE SENSITIVE DETECTION OF THE D816V AND OTHER KIT GENE MUTATIONS IN SYSTEMIC MASTOCYTOSIS

EHA Library, Caterina De Benedittis, 100011

RUXOLITINIB VS BEST AVAILABLE THERAPY IN PATIENTS WITH POLYCYTHEMIA VERA TREATED IN THE RESPONSE STUDY: A SUBGROUP ANALYSIS OF HYDROXYUREA- AND NON-HYDROXYUREA–TREATED PATIENTS

EHA Library, Francesco Passamonti, 100012

RISK OF PREGNANCY COMPLICATIONS AND EFFECT OF DIFFERENT TREATMENTS IN WOMEN WITH ESSENTIAL THROMBOCYTHEMIA: A RETROSPECTIVE MONOCENTER ANALYSIS OF 62 PREGNANCIES.

EHA Library, Silvia Betti, 100013

LONG-TERM OUTCOMES FOLLOWING REDUCED-INTENSITY STEM CELL TRANSPLANTATION: THE CRITICAL IMPORTANCE OF THE DEVELOPMENT OF GRAFT-VERSUS-HOST DISEASE

EHA Library, Emilie Nevill, 100014

EFFICACY OF RUXOLITINIB IN MYELOID NEOPLASMS WITH PCM1-JAK2 FUSION GENE

EHA Library, Ilaria Carola Casetti, 100015

UTILITY OF CHIMERISM ANALYSIS IN DETECTION OF POST-TRANSPLANT DISEASE RELAPSE IN PATIENTS WITH MYELOID NEOPLASMS UNDERGOING REDUCED INTENSITY CONDITIONING ALLOGENIC HEMATOPOIETIC CELL TRANSPLANTATION

EHA Library, Mehrdad Hefazi, 100016

PREVALENCE OF EOSINOPHILIAS (EOS), IDIOPATIC HYPEREOSINOPHILIA AND HYPEREOSINOPHILIC SYNDROME (HES) IN A LARGE (ONE MILLION) POPULATION IN NORTH ITALY (THE ROMAGNA GREATER AREA)

EHA Library, Michela Rondoni, 100017

EXCELLENT LONG-TERM OUTCOME OF AUTOLOGOUS TRANSPLANTATION WITH INTERMEDIATE-DOSE INTENSIVE MELPHALAN (100 MG/M2, MEL100) FOR MULTIPLE MYELOMA: A SINGLE CENTRE STUDY.

EHA Library, Kentaro Fukushima, 100018

IMPACT OF DONOR AGE ON PERIPHERAL BLOOD AND BONE MARROW HEMATOPOIETIC STEM CELL HARVEST

EHA Library, Hyunsoo Cho, 100019

BASELINE PERIPHERAL BLOOD CD34+ CELL COUNT DOES NOT INFLUENCE PLERIXAFOR SUCCESS RATE

EHA Library, Ana Ferreira Baptista, 100020

AUTOLOGOUS PERIPHERAL BLOOD CD34+ CRYOPRESERVED WITH 5% DIMETHYL SULFOXIDE COMPARED TO 10%: BETTER VIABILITY OF CD34+ AND NO NEUROLOGICAL SIDE EFFECTS

EHA Library, Vincenzo Pavone, 100021

SINGLE VERSUS TANDEM AUTOLOGOUS STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA – RETROSPECTIVE STUDY

EHA Library, Patricia SILVA, 100022

IS ALLOGENEIC STEM-CELL TRANSPLANTATION AN OPTION FOR PATIENTS WITH ACUTE LEUKEMIA AND MYELODISPLASTIC SYNDROME TRANSPLANTED WITH ACTIVE DISEASE? A CENTER EXPERIENCE

EHA Library, Miguel Alcoceba, 100023

THE UTILITY OF FLUORESCENCE LIFETIME IMAGING IN ROUTINE BONE MARROW SMEARS

EHA Library, Irene Lorand-Metze, 100025

CD3+/CD8+/CD16+/CD56-/CD57+ T-LGLL REPRESENTS A DIFFERENT SUBSET WITH DISTINCT CLINICAL AND BIOLOGICAL FEATURES

EHA Library, Gregorio Barilà, 100026

STAT5B MUTATION ANALYSIS IN A COHORT OF T-LGL LEUKEMIA PATIENTS

EHA Library, Antonella Teramo, 100027

HUMAN MEMORY-LIKE NATURAL KILLER CELLS ABLE TO KILL NEOPLASTIC CELLS AS A TOOL FOR A NOVEL APPROACH OF ANTI-TUMOR CELL THERAPY

EHA Library, Daniela Montagna, 100028

IDENTIFICATION OF LEUKEMIC STEM CELL CANDIDATES IN AN ATL MOUSE MODEL OF HBZ TRANSGENIC MICE

EHA Library, Wakako Kuribayashi, 100029

UNTOUCHED GMP-GRADE PURIFIED ENGINEERED IMMUNE CELLS

EHA Library, Jürgen Kuball, 100031

PROTEIN KINASE CK2 IN DIFFUSE LARGE B-CELL LYMPHOMA: DEFINING ITS ROLE TO SHAPE NEW THERAPIES

EHA Library, Elisa Mandato, 100032

INHIBITORS OF MTOR/PI3K/AKT PATHWAY EXTEND THERAPEUTIC OPPORTUNITY IN WALDENSTRÖMS MACROGLOBULINEMIA CELLS THAT DISPLAY RESISTANCE TO BOTH ABT-199 AND IBRUTINIB.

EHA Library, Kasyapa Chitta, 100033

HIGH THROUGHPUT IN VITRO COMBINATION SENSITIVITY SCREEN IN HEMATOLOGIC MALIGNANCIES WITH DUVELISIB, A DUAL PI3K-DELTA,GAMMA INHIBITOR

EHA Library, Kerrie Faia, 100034

HEMOGLOBINOPATHIES WITH HIGH OXYGEN AFFINITY

EHA Library, Williana Torres, 100036

NK CELLS CYTOTOXICITY IS AFFECTED BY VARIOUS BTK INHIBITORS

EHA Library, Marta Siernicka, 100037

VDJH USAGE IN TRANSFORMED FOLLICULAR LYMPHOMA

EHA Library, Maria Garcia Alvarez, 100038

HB PUERTA DEL SOL, HB VALDECILLA, HB GRAN VÍA, HB MACARENA, AND HB EL RETIRO: DESCRIPTION OF 5 NEW HEMOGLOBINOPATHIES

EHA Library, Felix De La Fuente Gonzalo, 100039

WALDENSTROM MACROGLOBULINEMIA CELLS WITH PLASMACYTIC-PREDOMINANT FEATURES ARE INSENSITIVE TO DISRUPTION OF B-CELL RECEPTOR SIGNALING BUT RETAIN HEIGHTENED SENSITIVITY TO PROTEOTOXIC STRESS.

EHA Library, Kasyapa Chitta, 100040

THE QUESTIONING OF THE NEED FOR MONTHLY MONITORING OF PROTENURIA AMONG PATIENTS WITH BETA THALASSEMIA MAJOR USING DEFERASIROX

EHA Library, fatma Gümrük, 100041

OFATUMUMAB OVERCOMES CD59-DEPENDENT RESISTANCE TO COMPLEMENT-DEPENDENT CYTOTOXICITY IN HUMAN B-CELL LYMPHOMA MODEL

EHA Library, Michal Dwojak, 100042

IDIOPATHIC AND CONGENITAL ERYTHROCYTOSIS: A STUDY OF A LARGE COHORT.

EHA Library, Maria Luigia Randi, 100043

ANALYSIS OF THE IGVH SOMATIC MUTATIONS IN SPLENIC MARGINAL ZONE LYMPHOMA

EHA Library, Hunan Julhakyan, 100045

DESCRIPTIVE ANALYSES OF DEFERASIROX SAFETY AND EXPOSURE IN PATIENTS AGED >65 VERSUS 18 TO ≤65 YEARS

EHA Library, Maria Domenica Cappellini, 100046

DEFERASIROX IMPROVES LIVER FIBROSIS IN Β THALASSAEMIA MAJOR PATIENTS. A 5 YEARS FOLLOW UP STUDY.

EHA Library, Efthimia Vlachaki, 100047

FREQUENCY OF AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME IN CHILDREN WITH CHRONIC IMMUNE CYTOPENIAS AND NEWLY DIAGNOSED LYMPHOMA

EHA Library, Zéhre Kaya, 100048

25-OH VITAMIN D DOWN-REGULATES IN VITRO PRODUCTION OF ANTI-ERITHROCYTE ANTIBODIES IN AUTOIMMUNE HAEMOLYTIC ANAEMIA

EHA Library, Bruno Fattizzo, 100049

INFECTIONS IN CHILDREN WITH CHRONIC NEUTROPENIA-A 13-YEAR EXPERIENCE IN A TERTIARY CARE CENTER

EHA Library, Madalina Schmidt, 100050

OUTCOME OF LANGERHANS CELL HISTIOCYTOSIS IN CHILDREN UNDER THE AGE OF 24 MONTHS- LCH-III PROTOCOL

EHA Library, Maria Moschovi, 100051

HYPERTRYPTASEMIA OF UNCERTAIN SIGNIFICANCE: A NOVEL CONDITION DETECTED IN A SCREEN OF 1330 UNSELECTED CASES IN A HEMATOLOGY CENTER

EHA Library, Katharina Blatt, 100052

AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME IN A FAMILY WITH PYRUVATE KINASE DEFICIENCY

EHA Library, Marina Economou, 100053

THE RESEARCH PARAMETER NEUT-X IN VITAMIN B12 DEFICIENCY

EHA Library, Athanasia Agorasti, 100054

CHRONIC NEUTROPENIA IN CHILDHOOD – EXPERIENCE FROM A SINGLE CENTER

EHA Library, Tuba Hilkay Karapınar, 100055

TISSUE DOPPLER IMAGING IN CHILDREN WITH SICKLE CELL DISEASE: EVALUATION OF PULMONARY HYPERTENSION

EHA Library, ILHAM YOUSSRY , 100056

LONG TERM TREATMENT WITH CONTINUOUS LOW DOSE LENALIDOMIDE RESULTS IN PET/CT DOCUMENTED EXCELLENT PARTIAL REMISSION IN A PATIENT WITH SEVERE MULTI-SYSTEMIC LANGERHANS CELL HISTIOCYTOSIS

EHA Library, Alexander Burchardt, 100057

CORRELATION OF GENOTYPE WITH PHENOTYPE IN BETA THALASSAEMIA INTERMEDIA IN SRI LANKA

EHA Library, Shiromi Perera, 100058

IMPROVING MACROCYTOSIS DIFFERENTIAL DIAGNOSIS BY RDW-SD

EHA Library, Telma Nascimento, 100059

USEFULLNESS OF SERUM FERRITIN LEVEL > 10,000 NG/ML TO DIAGNOSIS HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS (HLH) IN ADULTS.

EHA Library, Ernesto ColoradoLedesma, 100060

EFfiCACY OF HIGH-DOSE METHYLPREDNISOLONE AS A fiRST-LINE THERAPY IN ADULT PATIENTS WITH IDIOPATHIC THROMBOCYTOPENIC PURPURA

EHA Library, Emel Gurkan, 100061

THE SPECTRUM OF Α-THALASSEMIA AND Β–THALASSEMIA MUTATIONS IN SOUTH WEST IRAN

EHA Library, Bijhan Keikhaei, 100062

KLF10 GENE EXPRESSION AS A SECONDARY MODIFIER IN BETA THALASSEMIA AND SICKLE CELL DISEASE (SCD) PATIENTS AND A PHARMACOGENOMIC BIOMARKER FOR HYDROXYCARBAMIDE TREATMENT RESPONSE

EHA Library, Mohsen S Elalfy, 100063

EFFECTIVENES OF MAGNETIC RESONANCE IMAGING FOR MEASURING OF PITUITARY IRON OVERLOAD IN PATIENTS WITH THALASSEMIA

EHA Library, Yesim Oymak, 100064

GRANULOCYTE TRANSFUSIONS IN THE TREATMENT OF SEVERE INFECTIONS DURING PROLONGED NEUTROPENIA: SINGLE CENTER EXPERIENCE IN YEARS 2005 - 2014

EHA Library, Edgar Faber, 100065

THE ROLE OF REGULATORY T CELLS IN IMMUNE THROMBOCYTOPENIA OF CHILDHOOD

EHA Library, Maria Stratigaki, 100066

BK VIRUS-HEMORRHAGIC CYSTITIS FOLLOWING ALLOGENEIC STEM CELL TRANSPLANTATION: CLINICAL CHARACTERISTICS AND UTILITY OF LEFLUNOMIDE TREATMENT

EHA Library, Young Hoon Park, 100067

A COMPARISON OF ORAL LEVOFLOXACIN AND CEFEPIME IN PATIENTS WITH LOW-RISK FEBRILE NEUTROPENIA BY THE JAPAN FEBRILE NEUTROPENIA STUDY GROUP

EHA Library, Isao Yoshida, 100068

LONGITUDINAL RISK OF HERPES ZOSTER IN PATIENTS WITH NON-HODGKIN LYMPHOMA RECEIVING CHEMOTHERAPY: A NATIONWIDE POPULATION-BASED STUDY

EHA Library, SHIH-FENG CHO, 100069

MACROPHAGES FROM SEPSIS SURVIVING MICE PRESENT DIFFERENTIAL GENE EXPRESSION ASSOCIATED WITH AN IMMUNOTOLERANT PROFILE

EHA Library, Eduardo Rego, 100070

NEUTROPHIL CD64 INDEX AS A BIOMARKER OF EARLY SEPSIS IN MALIGNANT HEMATOLOGIC DISEASE

EHA Library, Shang yuxi, 100071

FIVE CASES OF PNEUMOCYSTIS PNEUMONIA (PCP) INFECTION IN PATIENTS FOLLOWING TREATMENT WITH BENDAMUSTINE / RITUXIMAB: PROPHYLAXIS SHOULD BE CONSIDERED AS STANDARD PRACTICE

EHA Library, Emma Groarke, 100072

SEVUPARIN DEMONSTRATES ANTI-ADHESIVE EFFECTS IN MALARIA PATIENTS SUGGESTING ITS POTENTIAL CLINICAL BENEFITS IN SEVERE MALARIA AND SICKLE CELL DISEASE

EHA Library, Anna M Leitgeb, 100073

SAFETY OF BIOSIMILAR FILGRASTIM IN PATIENTS WITH LYMPHOMA AND MYELOMA UNDERGOING NEUTROPENIA-INDUCING CHEMOTHERAPY: A SUBANALYSIS OF THE NEXT STUDY

EHA Library, Stéphane Lepretre, 100074

SYMPTOMS, QUALITY OF LIFE AND HEALTH CARE UTILISATION IN MULTIPLE MYELOMA – A LONGITUDINAL STUDY OF PREDICTIVE DEMOGRAPHIC AND CLINICAL FACTORS

EHA Library, Christina Ramsenthaler, 100075

THE EFFICACY OF POLYVINYLPYRROLIDONE – ZINC GLUCONATE AND TAURINE GEL (GEL X) IN PROPHYLAXIS AND TREATMENT OF ORAL MUCOSITIS IN CHILDREN TREATED WIH CHEMOTHERAPY

EHA Library, Anca Colita, 100076

INFECTION AND COLONIZATION BY CARBAPENEM RESISTANT KLEBSIELLA PNEUMONIAE IN HAEMATOLOGY PATIENTS

EHA Library, Maria Dolores Madrigal, 100077

PROGNOSTIC VALUE OF NEURO-PSYCHOLOGICAL PARAMETERS IN CLINICALLY FIT OLDER PATIENTS WITH HEMATOLOGICAL MALIGNANCIES

EHA Library, Dominique BRON, 100078

NOA PROGRAM INFLUENCING SURVIVAL IN CML PATIENTS FROM RESOURCE CONSTRAINT SETTINGS

EHA Library, Uday Yanamandra, 100079

HEALTH-RELATED QUALITY OF LIFE IN LEBANESE CHILDREN WITH SICKLE CELL DISEASE

EHA Library, Adlette Inati, 100080